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In most mammals the peptide hormone relaxin is a key physiological component
regulating early pregnancy and birth. However, synteny analysis shows that the gene
encoding ovarian relaxin-2 is deleted in cows and sheep. While, these ruminants
appear to exhibit a relaxin-like physiology, as in other mammals, until now a molecular
understanding of this has been lacking. Cloning and expression analysis of the cognate
bovine receptor for relaxin, RXFP1, as well as of the structurally related receptor, RXFP2,
in female tissues, shows that these are expressed in a similar way to other mammals.
RXFP1 transcripts are found in ovarian theca cells, endometrium, and myometrium,
whereas RXFP2 transcripts are expressed in ovarian theca cells, oocytes, as well as
in myometrium. Transfection of receptor-expressing gene constructs into HEK293 cells
indicates that bovine RXFP1 has a greater EC50 at 10–50 nM for porcine or human
relaxin, compared to human RXFP1. For bovine RXFP2, in contrast, the EC50 is <1 nM
for its cognate ligand, bovine INSL3, but also 10–30 nM for porcine or human relaxin.
Functional analysis shows that bovine myometrial cells are able to respond to exogenous
relaxin and INSL3 with a significant increase in cAMP. Although expressing mRNA for
both RXFP1 and RXFP2, bovine follicular theca cells only respond to INSL3 with a
dose-dependent increase in cAMP. Altogether the results suggest that the cow is able
to compensate for the missing hormone, and moreover imply that relaxin analogs could
offer an important therapeutic option in treating female ruminant infertility.
Keywords: relaxin, INSL3, RXFP1, RXFP2, follicle, endometrium, bovine
INTRODUCTION
The relaxin family of peptide hormones includes, besides relaxin (RLN2), also relaxin 3 (RLN3),
insulin-like peptide 3 (INSL3), INSL5, and INSL6. Additionally, within higher primates and
humans there is RLN1 and INSL4. RLN3 and INSL5 appear in most mammals to be restricted
in expression to the brain and gut, respectively, and act through G-protein coupled receptors,
referred to as RXFP3 and RXFP4, though the former peptide can also act, but with reduced affinity,
at RXFP1 (Bathgate et al., 2006). RLN2 and INSL3 on the other hand are usually expressed in
reproductive tissues of both sexes and act at a different subclass of GPCRs, respectively, RXFP1
and RXFP2, which are characterized by large extracellular domains and a superficial similarity to
the receptors for the gonadotropin hormones (Bathgate et al., 2006). As their names suggest, the
relaxin family of peptides share the basic scaffold of relaxin and insulin, with A and B chains linked
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by inter- and intra-peptide cysteine sulfhydryl groups, and a
connecting C-peptide which may or may not be processed upon
in vivo synthesis (Ivell et al., 2011).
For many years there has been a controversy surrounding
the existence or not of relaxin in ruminants, including cattle,
sheep, and goats (Hartung et al., 1995). A RLN2 homologous
molecule is definitely expressed at the mRNA and/or protein
levels in related ungulates, such as pigs, camels, llamas, and
horses (James et al., 1977; Stewart et al., 1991; Bravo et al.,
1996; Hombach-Klonisch et al., 2000; ncbi database: www-ncbi-
nlm-nih-gov). But extensive searching by a range of molecular
techniques has failed to identify related transcripts in ruminants,
except for a partially deleted sequence representing part of the
A-chain in sheep (Roche et al., 1993). Proving the absence of
a gene even with the extensive genomic sequence available has
been difficult, though there appears to be consensus now based on
studies of chromosomal synteny that there has been a significant
deletion in the bovine genome on chromosome 8, corresponding
to where the RLN2 gene should have been located (Figure 1).
Why there has been controversy is due to earlier reports at the
protein level of relaxin-like immunoreactive entities in bovine
tissues and seminal plasma (Fields et al., 1980; Kohsaka et al.,
2003), correlating to evident relaxin-like physiologies similar to
those described in species like the pig. It would appear that
in ruminants some antibodies which had been raised against
porcine relaxin may have been cross-reacting with some other
possibly related peptide (Ivell et al., 2011). At the time of these
earlier studies the existence of other relaxin-like peptides was
unknown, and thus could not be controlled for. In spite of the
uncertainty relating to the existence or not of a RLN2 homolog
in ruminants, there is nevertheless good evidence for a functional
relaxin-dependent physiology, at least in cows. Porcine relaxin
applied either locally or systemically to beef cows at term elicited
a classic softening and dilatation response, thereby influencing
calving period (Musah et al., 1987). Moreover, porcine relaxin
applied to bovine luteal cells in culture significantly suppressed
oxytocin production by these cells (Musah et al., 1990). More
recently, relaxin was shown significantly to affect bovine sperm
functional parameters (Miah et al., 2011).
It therefore appears that in ruminants such as the cow, there
are physiologies which in non-ruminant species are governed
by the peptide hormone relaxin, such as parturition, but which
appear to proceed relatively normally in the absence of the
hormone. Indeed, as a corollary to this, exogenous relaxin or
its analogs may offer interesting therapeutic opportunities in
ruminants. The present study was undertaken to examine the
receptors for relaxin and the related peptide INSL3 in the cow,
namely bRXFP1 and bRXFP2, in order to address the question
whether in the absence of endogenous ligand bRXFP1 has in
any way lost functionality, and/or whether another relaxin-like
peptide might be substituting for relaxin in this species.
MATERIALS AND METHODS
Bovine Tissues and Cells
Bovine tissues were obtained from the local slaughterhouse.
Tissue collection was in accordance with German, British and
European laws and provisions for ethical regulation. Cumulus-
oocyte complexes (COCs) were collected and categorized exactly
as in Janowski et al. (2012). For oocyte RNA preparation, COCs
were mechanically denuded using a glass pipette followed by a
2 min trypsin incubation (1x Trypsin-EDTA solution; T4174;
Sigma, Deisenhofen, Germany) to remove residual cumulus
cells, then frozen at −80◦C. Bovine myometrial cells were
prepared from excised uteri exactly as in Heng et al. (2008).
The isolated myometrial cells were plated at 6,000 cells/well
in a 48-well plate and cultured at 37◦C with 5% CO2 for
5 days before stimulation. Bovine ovaries without an obvious
corpus luteum were selected for the isolation of granulosa
and theca interna cells from mid-phase antral follicles (ca. 6–
10 mm diameter) using standard procedures (Holtorf et al.,
1989; Bathgate et al., 1999). Follicular fluid, including COCs
and granulosa cells, was aspirated from the follicles, and
collected in granulosa culture medium (DMEM/F-12 (1:1) with
1% bovine fetal serum, 1% antibiotic-antimycotic (ABAM), 2
mM L-glutamine). After manually removing the COCs, the
granulosa cells were harvested by centrifugation (150 g, 10
min) and rinsed once with culture medium as above. Four
to six millimeters follicles were obtained by dissection. The
theca interna layer of mid-phase antral follicles was peeled
off and digested with collagenase IV (1 mg/ml) in Medium
199, including trypsin inhibitor (100µg/ml) at 38◦C for 1 h.
The isolated theca cells were collected and washed in Medium
199 with 1% ABAM. After an isotonic shock to eliminate red
blood cells, the theca cells were seeded at 20,000 cells/well in
a 48-well plate in theca culture medium (McCoy’s 5A medium,
including 1% ABAM, 2 mM L-glutamine, 10 mM HEPES, 0.1%
BSA, 10 ng/ml bovine insulin, 5µg/ml bovine transferrin, and
5 ng/ml sodium selenite) and incubated at 38◦C with 5% CO2
for ∼40 h before stimulation, as indicated. All chemicals and
media were from Sigma. Primary bovine mammary epithelial
cells (MECs) were prepared according to Yang et al. (2006)
and were a generous gift from Professor Hans-Martin Seyfert
(Dummerstorf).
Follicular Fluid Analysis
In a separate approach, follicular fluids from medium-sized
(diameter 3–6 mm) and large (diameter 6–10 mm) antral follicles
of freshly collected slaughterhouse ovaries were individually
aspirated, flushed with an additional 100µl of Dulbecco’s
phosphate buffered saline (DPBS; BioWhittaker, Lonza,
Switzerland), and collected into separate tubes. After removal
of COCs and brief centrifugation to separate other cells, the
supernatants were analyzed for progesterone and estradiol using
established in-house radioimmunoassays (Christenson et al.,
2013) and for bovine INSL3 by highly specific time-resolved
fluorescent immunoassay (TRFIA; Anand-Ivell et al., 2011).
Because of inaccuracies in measuring individual antral fluid
volumes, hormones were first calculated and compared as total
amount per follicle, or as estradiol/progesterone ratio. These
individual values were then converted to mean concentrations
per follicle by applying average volumes for 3–6 mm follicles of
35µl and for 6–10mm follicles of 180µl after accounting for
somatic cells and COCs.
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FIGURE 1 | Gene synteny for the corresponding regions of the DMRT1 locus in the relevant chromosomes for human, bovine, ovine, equine, and porcine genomes,
based on the latest annotation lists and sequence information in the NCBI database (release Dec 2016). The region between INSL6 and PLGRKT is expanded in the
human genome to accommodate the recent local anthropoid gene duplications giving rise to INSL4 and RLN1. The equivalent region in horses and pigs is shorter and
accommodates only a single member of the relaxin family, RLN2, representing the primitive mammalian constellation. In sheep and cows this region is reduced again,
with a partial or complete deletion of the RLN2 gene, respectively. In sheep, only a remnant corresponding to the A-chain encoding exon 2 of the RLN2 gene is present.
Oocyte Analysis and In vitro Embryo
Production
COCs were collected from 3 to 6 mm medium-sized bovine
follicles, as above, and subjected to brilliant cresyl blue (BCB)
staining to indicate developmental competence, as previously
described (Janowski et al., 2012). For in vitro embryo production,
COCs were pooled, washed in DPBS, and then subjected to in
vitro maturation exactly as described previously (Janowski et al.,
2012). The COCs were then fertilized in vitro using frozen-
thawed bovine semen, presumptive zygotes manually denuded,
and resulting embryos cultured at 38.5◦C in 5%CO2, 5% O2, and
90% N2 up to blastocyst stage (day 8; Janowski et al., 2012).
RT-PCR Analysis for RXFP1 and RXFP2
Transcripts
Total RNA from endometrial biopsies, myometrial, granulosa,
and theca cells, as well as oocytes and embryos was prepared
using the RNAqueous-micro total RNA isolation kit (Ambion,
Thermo-Fischer, Darmstadt, Germany) according to the
manufacturer’s instructions, and then single strand cDNA was
prepared following the procedure described in Heng et al. (2008).
Semi-quantitative RT-PCR was carried out using the primers
listed in Supplementary Table 1, designed using the Primer3
software applied to sequences XM_002694415 (bRXFP1)
and NM_001304277 (bRXFP2). 0.25µM of each primer pair
was used to amplify 1µl of cDNA using EmeraldAMP MAX
HS PCR master mix (50% of the reaction volume) (Takara-
Clontech, Heidelberg, Germany). For each reaction, DNA was
denatured at 95◦C for 45 s, annealing was carried out at the
temperature indicated in the figure legends, with elongation
at 72◦C for 1 min, for a total of 35 cycles. As control for
the integrity of the RNA, all samples were also validated for
the expression of the housekeeping gene bovine rp27a (not
shown).
All PCR products were analyzed by gel electrophoresis on a 2%
agarose gel including 1% ethidium bromide, with visualization
using a GelDoc XR system (Bio-Rad, Gladesville, Australia).
For PCR product sequencing, the DNA in each gel band
was extracted using the MinElute Gel Extraction Kit (Qiagen,
Hilden, Germany), and sequenced (Eurofins-MWG, Ebersberg,
Germany).
Bovine RXFP1 and RXFP2 Gene
Constructs and Transfection
Preliminary studies, prior to the publication of the bovine
genome project, had employed heterologous RT-PCR primers,
derived from human sequence information, together with
RNA from selected bovine tissues. Initial sequence information
obtained was subsequently fully confirmed by the bovine
genome project, which is used here for reference. Having
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FIGURE 2 | Schematic exon organization of the bovine RXFP1 gene (above) indicating both the position of the novel exon 10a and the locations of the oligonucleotide
primers (triangles) used for RT-PCR analysis. The locations of encoded transmembrane regions are indicated by the internal cross-hatched rectangles. The
corresponding exon structures of various splice variants identified in this study by RT-PCR, or as pre-existing EST sequences, are indicated below. Additionally,
RNASeq analysis (NCBI database; release Dec. 2016) has identified splice variants with the following deletions: 14, 12, 110-11-12, 110-11, 16, 8, 112, 16, 18.
FIGURE 3 | Schematic exon organization of the bovine RXFP2 gene (above) indicating both the position of the novel exons 5a and 11a, and the locations of the
oligonucleotide primers (triangles) used for RT-PCR analysis. The locations of encoded transmembrane regions are indicated by the internal cross-hatched rectangles.
The corresponding exon structures of various splice variants identified in this study by RT-PCR, or as a pre-existing EST sequence, are indicated below.
confirmed by RT-PCR the correct sequences for the full-
length functional bRXFP1 and bRXFP2 transcripts, expression
constructs were generated, whereby the signal peptides of the
two receptor sequences were replaced by the signal peptide-
encoding sequence from the bovine prolactin gene, together
with an intermediate short FLAG sequence, exactly as used
previously for the expression of the human RXFP1 and RXFP2,
and other G-protein coupled receptors (Hsu et al., 2000, 2002).
The two final bovine constructs were generated from assembled
multiple oligonucleotides (custom gene synthesis by GeneArt,
Regensburg, Germany), their sequences confirmed, and inserted
into the vector pcDNA3.1/Zeo(+) (Invitrogen) for expression.
For transfection, the Neon electroporation system
(Invitrogen) was used: the bRXFP1 or bRXFP2 expression
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FIGURE 4 | Semi-quantitative RT-PCR analysis for bRXFP1 transcripts of RNA derived from various bovine cells and tissues as indicated, or water controls (lane 1, in
all panels). MEC, bovine mammary epithelial cells. PCR primers used are shown in white within each panel. White triangles indicate the position of the correctly spliced
PCR product. M, 100 bp DNA ladder used as size markers. PCR conditions (primers, annealing temperature, expected size):#503–#504, 62◦C, 301 bp; #513–#514,
62◦C, 337 bp; #515–#516, 62◦C, 316 bp; #529–#530, 62◦C, 692 bp.
plasmids were mixed with HEK 293T cells in a ratio of ∼0.2µg
DNA/50,000 cells/well (48-well plate), and pulsed at 1,300 V
for 30 ms to transfect the DNA into the cells. Plasmids were
allowed to express for 24 h with the transfected cells cultured
in DMEM/F12 (1:1) at 37◦C with 5% CO2. In parallel, HEK
293T cells which had been permanently transfected with human
RXFP1 or human RXFP2 (Heng et al., 2008) were plated at
50,000 cells/well in a 48-well plate, and cultured overnight
in DMEM/F12 (1:1) with 10% bovine fetal serum, 2mM
L-glutamine and 1% Penicillin-Streptomycin at 37◦C with
5% CO2.
Cell Culture and Analysis
For the transient and permanently transfected HEK 293T cells
and the primary myometrial (6,000 cells/well) and theca cells
(20,000 cells/well), after the initial pre-culture period (as above)
mediumwas changed and supplemented or not with 1mM IBMX
(3-isobutyl-1-methylxanthine; Sigma) as indicated (30min for
myometrial cells, 10min for theca cells). Following this pre-
incubation, cells were supplemented or not with various peptides,
also as indicated in the figure legends, and incubation continued
for a further 20min. Total cAMP was extracted from the
combined cells and culturemedium from eachwell andmeasured
by time-resolved fluorescent immunoassay (TRFIA) as described
in Anand-Ivell et al. (2007). cAMP production by the transfected
HEK 293 cells was measured directly (range1–243 pmol/ml);
cAMP from primary myometrial and theca cells made use of the
more sensitive TRFIA employing sample acetylation (detection
range 0.04–9.72 pmol/ml).
Statistics
All data were analyzed and plotted using GraphPad Prism 6.
The EC50 values were calculated by non-linear regression of log
(agonist) against response (three parameter). All column data
Frontiers in Physiology | www.frontiersin.org 5 June 2017 | Volume 8 | Article 359
Dai et al. Bovine RXFP1 and RXFP2
FIGURE 5 | Semi-quantitative RT-PCR analysis for bRXFP1 transcripts of RNA
derived from two independent batches of purified bovine myometrial cells (M)
as indicated. C, water controls. PCR primers used are shown above each
panel. White triangles indicate the position of the correctly spliced PCR
product. A 100 bp DNA ladder was used as size markers on the right side of
each gel image. PCR conditions (primers, annealing temperature, expected
size) as in Figure 4 plus:#505–#506, 62◦C, 349 bp; #507–#508, 62◦C, 175
bp; #503–#508, 62◦C, 753 bp; #511–#512, 62◦C, 304 bp.
were analyzed by ANOVA followed by Neuman-Keuls post-hoc
test.
RESULTS
Primary Structure of the Bovine RXFP1 and
RXFP2 Receptors
At the outset of this project bRXFP1 and bRXFP2 sequence
information for the bovine in the NCBI genome database had
FIGURE 6 | Semi-quantitative RT-PCR analysis for bRXFP2 transcripts of RNA
derived from various bovine cells and tissues as indicated, or water controls
(lane 2). MEC, bovine mammary epithelial cells. PCR primers used are shown
in white within each panel. White triangles indicate the position of the correctly
spliced PCR product. A 100 bp DNA ladder is used as size markers in lane 1
within each panel. PCR conditions (primers, annealing temperature, expected
size):#519–#520, 62–58◦C touchdown, 291 bp; #521–#522, 62–60◦C
touchdown, 312 bp.
been missing, incomplete, and in part incorrect, based as it
was on partial homologies to other species and application
of exon-finding algorithms. RT-PCR strategies were therefore
applied using oligonucleotide primers which appeared to be
homologous between different species, and using various bovine
tissues as a source of potential receptor transcripts. The
latest release of the NCBI database (Jan. 2017) now includes
complete putative transcript sequences (excluding 5′UTRs) for
bRXFP1 (XM_610789.7 and XM_002694415.3) and bRXFP2
(NM_001304277.1), based, however, still on predictions using
exon-finding algorithms, homologies to known RXFP1 and
RXFP2 sequences in other species, and validated by global RNA-
Seq sequence information. Our independent RT-PCR analyses
together with genomic BLAST confirmed these two sequences
at the expressed transcript level and their corresponding exon-
intron structures (Figures 2, 3).
Additionally, our experience from working with RXFP1 and
RXFP2 in other species has highlighted the in vivo generation
of alternatively spliced transcripts for both genes, particularly
involving the short 5′ exons representing individual leucine-
rich repeats (Anand-Ivell et al., 2006; Heng et al., 2008). The
RT-PCR matrix developed to assess the bovine transcripts was
designed to identify possible splice variants in expressing cells
and tissues (Figures 2, 3). Indeed, in the bovine both genes
exhibited multiple splice variants, in which one or more exons
are missing, as well as alternative novel exons (Figures 2, 3).
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It is to be noted that none of the deleted exons, led to a
frame-shift or in-frame stop codons. In contrast, where there
appears to be the introduction of a novel exon (bRXFP1 exon
10a; bRXFP2 exons 5a and 11a) this indeed leads to an in-
frame stop codon in each case. Only where multiple PCR
products for a given cell type or tissue consistently indicate
the expression of a full-length, putatively functional transcript
can we declare that bRXFP1 or bRXFP2 may be functionally
expressed in that tissue. Although the RNA-Seq data included
in the NCBI database as validation of a particular sequence also
suggests the alternative loss of similar exons, the short-sequence
nature of RNA-Seq is not sufficient to absolutely discriminate
entire transcript structures as implied by the listed so-called
RXFP1 “splice variants” (accession numbers XM_010813810-
12, XM_010823315-17, XM_005217632, XM_005217635-36,
XM_005194978-79, XM_005194981-82).
Expression of RXFP1, RXFP2, and RLN 3 in
Cells and Tissues of the Female Bovine
Reproductive System
Applying the matrix of PCR primers indicated in Figures 2, 3,
various cells and tissues of the female reproductive system
were interrogated for the expression of bRXFP1 (Figures 4, 5)
and bRXFP2 (Figures 6, 7). Not all successful PCR primer
combinations are illustrated. bRXFP1 is consistently shown to be
expressed in the endometrium, myometrial cells, and theca cells,
though not in granulosa cells, nor in oocytes and early embryos
(not shown). Arrowheads indicate the correctly sized and
sequenced PCR products; alternatively sized products, evident
in most samples, and mostly as quantitatively minor bands,
proved on sequencing to represent splice variants. Myometrial
cells are shown in detail in Figure 5, whereby the dominant PCR
product always appears to represents the full-length bRXFP1
transcript.
In contrast, bRXFP2 is expressed as correctly sized PCR
products (arrowheads) only in theca cells and oocytes, and
weakly in myometrial cells. Other sized products, for example,
in early embryos, proved upon sequencing to be exclusively
splice variants. Detailed RT-PCR analysis for bovine oocytes
is shown in Figure 7, where the major product represents the
correct full-length transcript, and minor bands represent splice
variants.
RT-PCR analysis was additionally undertaken in all cell
and tissue samples from the female reproductive system for
transcripts representing bovine RLN3, since potentially this could
be a local ligand for RXFP1 in these tissues. For no sample could
any specific RLN3-related transcripts be identified (not shown).
INSL3 Concentration in Bovine Follicular
Fluid
INSL3 concentration was measured in follicular fluids from
either medium-sized (diameter 3–6 mm) or large (diameter 6–
10 mm) antral follicles from freshly collected ovaries. Total
INSL3 per follicle was very variable at 13.2 ± 13.8 ng (n =
115) and 24.5 ± 43.1 ng (n = 17), respectively (not significantly
different). Assuming approximate antral fluid volumes (also
FIGURE 7 | Semi-quantitative RT-PCR analysis for bRXFP2 transcripts of RNA
derived from purified bovine oocytes (lanes 2, 4, and 6) compared with water
controls (lanes 1, 3, and 5). PCR primers used are shown below the panel.
White triangles indicate the position of the correctly spliced PCR product. A
100 bp DNA ladder (M) was used as size markers on the right side of the gel
image. PCR conditions (primers, annealing temperature, expected size) as in
Figure 6 plus:#523–#524, 62◦C, 392 bp.
taking into account approximate cell mass) for each category of
35 and 180µl, respectively, this implies in vivo concentrations
of INSL3 of 376 and 136 ng/ml in bovine follicular fluid,
which approximately corresponds to the concentration of INSL3
observed in rat testicular interstitial fluid (ca. 400 ng/ml; ref).
There was no association between individual INSL3 amount
per follicle and either estradiol or progesterone concentration,
nor their ratio (data not shown). Nor was there any significant
difference in INSL3 content per follicle and the ability of
individual oocytes to stain with BCB or not.
Stimulation of Primary Cultures of Bovine
Myometrial and Theca Cells with RLN and
INSL3
From the RNA analysis, two cell types appeared to express
both bRXFP1 and bRXFP2 as apparently full-length functional
transcripts. To confirm this, primary myometrial cell cultures
were stimulated with either porcine RLN or bovine INSL3,
measuring acute cAMP production in the presence of
the phosphodiesterase inhibitor IBMX as endpoint. For
both peptides a significant stimulation was observed at all
concentrations applied (Figure 8A). For cultured bovine theca
cells, INSL3 (Figure 8C), but neither human nor porcine
relaxin (Figure 8B), was able significantly to stimulate cAMP
production in a dose-dependent manner. The fold-increase in
cAMP observed was similar to that seen for human primary cell
types (Anand-Ivell et al., 2007; Heng et al., 2008).
Transfection and Stimulation of Bovine
RXFP1 and RXFP2
Full-length transcripts for bRXFP1 and bRXFP2 were
synthesized, replacing the natural leader sequences with
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FIGURE 8 | Primary cultures of purified bovine myometrial (A) or theca cells (B,C) stimulated or not for 20 min with various concentrations of porcine relaxin (pRLN),
human recombinant relaxin (rhRLN) or bovine INSL3 in the presence of the phosphodiesterase inhibitor IBMX at 1 mM, measuring cAMP production as endpoint.
Significant difference from basal is indicated by asterisks (*p < 0.05; **p < 0.01; ***p < 0.001).
that of the bovine prolactin gene, as previously described
for the human equivalent receptors (Hsu et al., 2002), and
subcloned into the expression vector pcDNA3.1/Zeo (+).
These plasmids were transiently transfected into HEK293T
cells and acutely stimulated with various putative ligands
as indicated in Figures 9A,B. For bRXFP1 only porcine
RLN, recombinant human RLN2 and human RLN3 showed
any stimulation within the range of concentration applied
(Figure 9A). For bRXFP2 only INSL3 was effective at low
concentrations, though porcine RLN, rhRLN, but not RLN3,
could stimulate at very high concentration (Figure 9B). The
amounts of cAMP generated were similar to previously
published studies for the transfected human receptors
(e.g., Hsu et al., 2002; Heng et al., 2008). In parallel, similar
stimulations were carried out using permanently transfected
cells expressing human RXFP1 (hRXFP1) and hRXFP2
(Table 1). Whereas, hRXFP1 indicated EC50s for porcine and
human RLN of <1 nM, the corresponding values for bRXFP1
were 10.8 and 48.7 nM, respectively. Similarly for RLN3,
the EC50 value differed by almost one order of magnitude
(Table 1). For RXFP2, in contrast, EC50 values were largely
comparable between human and bovine receptors (Table 1).
For its cognate ligand INSL3, whether human or bovine,
the EC50s were consistently 0.6–0.7 nM, and for RLN of
different sources EC50 values ranged from 10 to 50 nM.
hRLN3 was unable to stimulate either hRXFP2 or bRXFP2
(Table 1).
DISCUSSION
Possibly because of the relatively high incidence of dystocia in
cows (Mee, 2008) and because of the marked relaxin-dependent
physiology in pigs as a closely related species, the pursuit of
a relaxin physiology in cows has pre-occupied reproductive
scientists for several decades (reviewed in Hartung et al., 1995).
Whilst it now appears that the RLN ligand is not expressed in
ruminants (Figure 1), the discovery of other relaxin-like peptides
has reopened the question. To address this, we have cloned and
studied the expression in the bovine female reproductive system
of the two related receptors bRXFP1 and bRXFP2, which in
other species specifically respond to RLN and the structurally
closely related INSL3. As anticipated from other recent studies
on the role of INSL3 in the bovine ovary (Glister et al., 2013),
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FIGURE 9 | Dose-response curves for cAMP production by HEK293T cells
transiently transfected with either bRXFP1 (A) or bRXFP2 (B) and stimulated
by increasing concentrations of porcine relaxin (pRLN), recombinant human
relaxin (rhRLN), relaxin 3 (RLN3), bovine INSL3 (bINSL3), or human INSL3
(hINSL3), as indicated.
bRXFP2 conforms structurally and functionally to RXFP2 from
other species, showing high specificity toward INSL3 (EC50 <
1 nM), and modest cross-reactivity with either porcine or human
RLN (EC50, 10–30 nM). It is expressed at a high level in ovarian
theca cells consistent with its role to promote androstenedione
synthesis in these cells (Glister et al., 2013; Anand-Ivell and Ivell,
2014). It is also expressed in oocytes, where it may be involved in
oocyte physiology (Kawamura et al., 2004), and at a low level in
bovine myometrial cells, as shown previously also for the human
(Heng et al., 2008). In the absence of any circulating relaxin
in the cow, bRXFP2 is exclusively activated only by INSL3. In
transfected cell systems bRXFP2 signals through adenylyl cyclase,
as does hRXFP2 (Heng et al., 2008), leading to an increase
in intracellular cAMP. Assessment of primary myometrial and
theca cell cultures also suggests an activation of adenylyl cyclase,
although this does not exclude activation of other protein kinase
A-dependent and -independent signaling pathways (Halls et al.,
2015).
The observation of significant amounts of bRXFP2 transcripts
in bovine oocytes is in agreement with observations in rodents
(Kawamura et al., 2004; Xue et al., 2014), as well as with
TABLE 1 | EC50 values for human and bovine RXFP1 and RXFP2.
Peptide bRXFP1 hRXFP1 bRXFP2 hRXFP2
pRLN 10.8 nMa 0.4 nMa 10.5 nMa >12 nMa,b
rhRLN 48.7 nM 0.9 nM 27.3 nM 53.9 nM
hRLN3 97.9 nM 14.6 nM n.d.c n.d.c
bINSL3 >1,000 nMb n.d.c 0.7 nM 0.6 nM
hINSL3 n.d.c n.d.c 0.6 nM 0.7 nM
insulin n.d.c n.d.c
IGF1 n.d.c n.d.c
IGF2 n.d.c n.d.c
aConcentrations for porcine RLN have been converted to nM assuming a MW of 6 kD
and a purity of 85%.
bdose-response curve had not reached an asymptote at the highest concentration used.
cn.d., Not determined; insufficient stimulation at highest concentration applied.
corresponding findings from the male gametes of rodents and
humans (Anand-Ivell et al., 2006; Filonzi et al., 2007). However,
the high apparent concentration of INSL3 in bovine follicular
fluid, together with the measured EC50 for bRXFP2, would
suggest that the oocyte receptor is either permanently occupied
through the antral phase, or permanently desensitized, or both.
It is possible that oocyte bRXFP2 plays an important role at
an earlier time-point in oocyte development before INSL3 is
markedly expressed in the follicle. Alternatively, it may become
important only after ovulation when the oocyte is liberated from
the high INSL3 environment. Further research will be needed to
examine these options.
An earlier study also showed significant amounts of INSL3
mRNA within the bovine corpus luteum (Bathgate et al., 1996).
Although, we did not revisit this structure in the present study,
future research will also focus on the role of both RXFP1 and
RXFP2 dependent physiology in luteal function.
The bRXFP1 receptor also appears to be functional, in
transfected cell systems responding to both porcine RLN and
hRLN, albeit with markedly increased EC50 values (10–50 nM).
Significantly, it also responds to hRLN3 (which retains 96%
amino acid homology to bRLN3) though again with a markedly
increased EC50 (∼100 nM) compared to the human receptor
(∼15 nM). This is important since it has been suggested that at
least in the brain RXFP1 may be a natural receptor for RLN3
(Meadows and Byrnes, 2015). It should be noted, however, that
higher EC50 values may be less relevant in cell systems where
receptor and expressed ligand are closely juxtaposed. Since we
could find no evidence for local RLN3 expression in cells of the
female reproductive system, it seems unlikely that RLN3 may
be a significant ligand for bRXFP1 in the female reproductive
system in vivo. Nevertheless, bRXFP1 remains functional, as
shown here by its apparently specific response in myometrial
cells, though not in theca cells, and by past studies showing
specific effects on bovine luteal cells in culture (Musah et al.,
1990) and in cervical softening and dilatation in vivo (Musah
et al., 1987).
The question remains, if the specific and unique ligand for a
receptor has been lost by mutation during ruminant evolution,
why is it that the receptor remains functional, albeit with an
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increased EC50 for an exogenous ligand, and is still expressed
in those cell types known to respond to RLN in other species?
In otherwise similar circumstances one would expect rather to
see an accumulation of missense mutations and deletions in
such a receptor gene or in its control regions, leading to a
loss of function and/or expression. This suggests that bRXFP1
is still functioning in vivo though with alternative activation
mechanisms. Besides, the possible selective effect of a brain
relaxin-3/RXFP1 system noted above, one possibility could be
that there are other non-relaxin ligands in vivo, possibly similar
to the C1q-tumor necrosis factor-related protein 8 (CTRP8)
peptide recently reported (Glogowska et al., 2013), or like
whatever molecules might activate the related orphan LGRs
(Hsu et al., 2000). An alternative possibility arises from the
known properties of hRXFP1, and probably hRXFP2, to form
homo- and hetero-dimers, also with other GPCRs, such as the
angiotensin receptor (Chow et al., 2014; Halls et al., 2015), which
in the absence of RLN might then be activated, for example,
by INSL3 alone. This would be particularly relevant in those
cells, such as myometrial or theca cells, where bRXFP1 and
bRXFP2 appear to be co-expressed. This might also explain the
prevalence of the various splice variants for bRXFP1 and bRXFP2
in which predominantly exons representing individual leucine-
rich repeats from the N-terminal extracellular domains of the
receptors aremissing, but without inducing any frame-shift. Such
variants could result in translated proteins with defective ligand-
binding and/or signaling properties, but whose transmembrane
and intracellular domains are intact. Such transcript variants
might act as inhibitors in a receptor dimerization situation (Kern
and Bryant-Greenwood, 2009). Further research will be necessary
to elucidate these details.
In conclusion, we have shown that cows indeed express
functional bRXFP1 receptors in cells of the female reproductive
system comparable to those in non-ruminant species. Although
ruminants do not express the normal ligand for this receptor, the
results strongly imply that cows would be amenable to exogenous
administration of RLN or its analogs in a therapeutic context, as
was suggested some 30 years ago for the treatment of dystocia
(Musah et al., 1987).
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